These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11697470)

  • 1. Comparison of the hanson microette and the Van Kel apparatus for in vitro release testing of topical semisolid formulations.
    Rapedius M; Blanchard J
    Pharm Res; 2001 Oct; 18(10):1440-7. PubMed ID: 11697470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an in vitro release method for topical particulate delivery systems.
    Lusina Kregar M; Dürrigl M; Rožman A; Jelčić Ž; Cetina-Čižmek B; Filipović-Grčić J
    Int J Pharm; 2015 May; 485(1-2):202-14. PubMed ID: 25772416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive approach to qualify and validate the essential parameters of an in vitro release test (IVRT) method for acyclovir cream, 5.
    Tiffner KI; Kanfer I; Augustin T; Raml R; Raney SG; Sinner F
    Int J Pharm; 2018 Jan; 535(1-2):217-227. PubMed ID: 28935255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Analytical Target Profile for the Development of an In Vitro Release Test Method and Apparatus Selection in the Case of Semisolid Topical Formulations.
    Szoleczky R; Kovács A; Berkó S; Budai-Szűcs M
    Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of formulation, receptor fluid, and occlusion, on in vitro drug release from topical dosage forms, using an automated flow-through diffusion cell.
    Rolland A; Demichelis G; Jamoulle JC; Shroot B
    Pharm Res; 1992 Jan; 9(1):82-6. PubMed ID: 1589414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical formulation studies with DEET (N,N-diethyl-3-methylbenzamide) and cyclodextrins.
    Proniuk S; Liederer BM; Dixon SE; Rein JA; Kallen MA; Blanchard J
    J Pharm Sci; 2002 Jan; 91(1):101-10. PubMed ID: 11782901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Apparatus and Adapter on In vitro Drug Release of Ophthalmic Semisolid Drug Products.
    Mekjaruskul C; O'Reilly Beringhs A; Qin B; Wang Y; Chowdhury P; Lu X
    Pharm Res; 2023 Sep; 40(9):2239-2251. PubMed ID: 37679656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Validated IVRT Method to Assess Topical Creams Containing Metronidazole Using a Novel Approach.
    Rath S; Kanfer I
    Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro release of nitroglycerin from topical products by use of artificial membranes.
    Wu ST; Shiu GK; Simmons JE; Bronaugh RL; Skelly JP
    J Pharm Sci; 1992 Dec; 81(12):1153-6. PubMed ID: 1491329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation factors affecting release of drug from topical formulations. 1. Effect of emulsion type upon in vitro delivery of ethyl p-aminobenzoate.
    Lalor CB; Flynn GL; Weiner N
    J Pharm Sci; 1994 Nov; 83(11):1525-8. PubMed ID: 7891268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and reproducibility of vertical diffusion cells for determining release rates from semisolid dosage forms.
    Hauck WW; Shah VP; Shaw SW; Ueda CT
    Pharm Res; 2007 Nov; 24(11):2018-24. PubMed ID: 17530388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equipment and method for in vitro release measurements on topical dosage forms.
    Sesto Cabral ME; Ramos AN; Cabrera CA; Valdez JC; González SN
    Pharm Dev Technol; 2015; 20(5):619-25. PubMed ID: 25318476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
    Kezutyte T; Drevinskas T; Maruska A; Rimdeika R; Briedis V
    Acta Pol Pharm; 2011; 68(6):965-73. PubMed ID: 22125963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of skin permeability for three diclofenac topical formulations: an in vitro study.
    Folzer E; Gonzalez D; Singh R; Derendorf H
    Pharmazie; 2014 Jan; 69(1):27-31. PubMed ID: 24601219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of additives on release and in vitro skin retention of flavonoids from emulsion and gel semisolid formulations.
    Dyja R; Jankowski A
    Int J Cosmet Sci; 2017 Aug; 39(4):442-449. PubMed ID: 28267214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro release testing method development for ophthalmic ointments.
    Bao Q; Shen J; Jog R; Zhang C; Newman B; Wang Y; Choi S; Burgess DJ
    Int J Pharm; 2017 Jun; 526(1-2):145-156. PubMed ID: 28461266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical release from topical formulations across synthetic membranes: infinite dose.
    Parks JM; Cleek RL; Bunge AL
    J Pharm Sci; 1997 Feb; 86(2):187-92. PubMed ID: 9040093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro release test (IVRT): Principles and applications.
    Shah VP; Simona Miron D; Ștefan Rădulescu F; Cardot JM; Maibach HI
    Int J Pharm; 2022 Oct; 626():122159. PubMed ID: 36067919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeic Acid in Dermatological Formulations: In Vitro Release Profile and Skin Absorption.
    Spagnol CM; Di Filippo LD; Isaac VLB; Correa MA; Salgado HRN
    Comb Chem High Throughput Screen; 2017; 20(8):675-681. PubMed ID: 28571540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development in release testing of topical dosage forms: use of the Enhancer Cell with automated sampling.
    Rege PR; Vilivalam VD; Collins CC
    J Pharm Biomed Anal; 1998 Sep; 17(8):1226-33. PubMed ID: 9800641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.